the endpoint inflammation score-which was based on high-sensitivity c-reactive protein, interleukin-6, tumor necrosis factor-α, and plasminogen activator inhibitor-1 levels-was significantly lower (p = 0.012) in the low-protein group (6.81 ± 2.32 versus 7.94 ± 1.94).